Results 21 to 30 of about 35,670 (265)
Tuberculosis in Children: New diagnostic Blood Tests
Canadian Journal of Infectious Diseases and Medical Microbiology, 2010 The interferon-gamma-release assays were developed to overcome the pitfalls and logistic difficulties of the tuberculin skin test (TST) for the diagnosis of latent tuberculosis infection (LTBI).
F Kakkar +4 more
doaj +1 more source
Clinical and Developmental Immunology, 2012 Background. Cutaneous drug reactions are common but diagnostically challenging due to phenotypic heterogeneity and simultaneous exposure to multiple drugs. These limitations prompted the development of diagnostic tests. Aims.
Ilan Goldberg +4 more
doaj +1 more source
Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. [PDF]
PLoS ONE, 2010 The measurement of Interferon gamma or Interferon gamma inducible protein (IP)-10 in antigen stimulated blood samples is suggested as an alternative method for latent tuberculosis (TB) diagnosis.
Basirudeen Syed Ahamed Kabeer +4 more
doaj +1 more source
Asian Journal of Medical Sciences, 2015 Objective: Guidelines encourage evaluation of an Interferon Gamma Release Assay (IGRA) in the local setting, particularly in low/ middle income, Bacillus Calmette Guerin (BCG) vaccinated populations where the assays have shown variable utility. The TSPOT.
Champa N Ratnatunga
doaj +1 more source
Journal of Research in Medical Sciences, 2021 Introduction: Identification of latent tuberculosis (TB) infection is important in kidney transplant candidates. Due to the absence of a gold standard, both tuberculin skin test (TST) and interferon-gamma release assays (IGRA) are used to screen patients.
Shiva Samavat +8 more
doaj +1 more source
The Tuberculin Skin Test Increases the Responses Measured by T Cell Interferon‐Gamma Release Assays [PDF]
Scandinavian Journal of Immunology, 2008 AbstractRUTI is a vaccine consisting of Mycobacterium tuberculosis bacilli grown in stress conditions that is fragmented, detoxified and liposomed. RUTI was designed to shorten the treatment of latent tuberculosis infection (LTBI) with isoniazid from 9 months to just 1 month, by additional treatment with two inoculations of RUTI 4 weeks apart.
Vilaplana, C +8 more
openaire +3 more sources
Tuberculin skin test and interferon‐γ release assays: Can they agree?
The Clinical Respiratory Journal, 2023 Introduction The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA).
João Almeida Santos +2 more
doaj +1 more source
Tuberculosis control in the Republic of Korea [PDF]
Epidemiology and Health, 2018 The incidence and mortality rates of tuberculosis (TB) in the Republic of Korea are 77 and 5.2 per 100,000 people, respectively (2016), which are the highest among the member countries of the Organization for Economic Cooperation and Development ...
Kyung Sook Cho
doaj +1 more source
Heliyon, 2023 Objective: Evidence regarding the role of cellular immunity in protecting against COVID-19 is emerging. To better assess immune status, simple and robust assays measuring specific T-cell responses associated with humoral responses are needed. We aimed to
Imane Saad Albichr +11 more
doaj +1 more source
Proposal to Revise the Screening Test for Latent Tuberculosis Infection in Close Contacts at Elementary Schools in Korea [PDF]
Journal of Preventive Medicine and Public Health, 2019 The 2018 National Guideline for Tuberculosis Control, which was published by the Korea Centers for Diseases Prevention and Control (KCDC), mandates conducting an epidemiological survey among close contacts of active tuberculosis patients at public ...
Jong-Myon Bae
doaj +1 more source